An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

NCT07182214 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1340

Last updated 2025-09-19

No results posted yet for this study

Summary

The purpose of this study is to observe whether miRNA and DNA methylation collected through liquid biopsy can serve as a biomarker for evaluating lung cancer.

Conditions

Interventions

OTHER

Collect blood sample

Collect venous blood sample from subjects prior fasting, any operation or treatment

Sponsors & Collaborators

  • Pharus Taiwan, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-05
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07182214 on ClinicalTrials.gov